190,000 Participants in Actos Study Reveal Alarming Trend
An ongoing study of nearly 200,000 Type 2 diabetes patients who rely on Actos (pioglitazone) for diabetes treatment has revealed disconcerting results. For patients continuing treatments beyond one year, nearly 40 percent demonstrate a notably higher risk in bladder cancer.
More recent findings from the study suggest that men who take Actos (pioglitazone) are measurably more susceptible than women to bladder cancer. While it’s true that superficial tumors may be “shaved off” using electrocautery, most cases of bladder cancer require painful, exhausting chemotherapy or radiation. In many cases, bladder cancer ultimately proves fatal.
The dangerous drug attorneys at Fears Nachawati have the experience and expertise to protect the legal rights and financial interests of Actos victims. Don’t stand by as your rights are violated! Find out how you and your loved ones can take action by contacting our dedicated legal representatives today. For your free consultation, call us at 1.866.545.8364 or email email@example.com. We’re ready to fight for you!